DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 1.83% to $755.02 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,976.44 and the Dow Jones Industrial Average rising 1.05% to 49,407.66.
The stock's rise snapped a three-day losing streak.
Regeneron Pharmaceuticals Inc. closed 8.05% below its 52-week high of $821.11, which the company achieved on January 9th.
The stock outperformed some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 0.82% to $344.68, Moderna Inc. (MRNA) fell 3.45% to $42.55, and Gilead Sciences Inc. (GILD) rose 0.66% to $142.89.
Trading volume (692,574) remained 273,383 below its 50-day average volume of 965,957.
Data source: Dow Jones Market Data, FactSet. Data compiled February 2, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 02, 2026 16:43 ET (21:43 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments